Effect of maleimide derivative inhibitor of protein kinases with antitumor activity on megakaryocytopoiesis in rats
Abstract
Keywords
Full Text:

References
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients–final analysis of a randomized, multicenter, phase III trial. / A. L. Petzer, D. Fong, T. Lion et al. // Haematologica, 2012. – Vol. 97, N 10. – P.1562–1569.
Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy / I. O. Sviezhentseva, T. P. Perekhrestenko, D. I. Bilko et al. // Experimental Oncology, 2015. – Vol. 37, N 1. – P. 70–72.
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: Results from the BELA trial / J. E. Cortes, D.-W. Kim, H. M. Kantarjian et al. // J. of Clinical Oncology, 2012. – Vol. 30, N 28. – P. 3486–3492.
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up / R. Larson, A. Hochhaus, T. P. Hughes et al. // Leukemia, 2012. – Vol. 26, N 10. – P. 2197–203.
Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target / F. Morabito, M. Gentile, J. F. Seymour et al. // Leukemia Lymphoma, 2015. – Vol. 56, N 12. P. 3250–3256.
Ruxolitinib versus standard therapy for the treatment of polycythemia vera / A. M. Vannucchi, J. J. Kiladjian, M. Griesshammer et al. // N. Engl J. Med., 2015. – Vol. 372, N 5. – P. 426–435.
Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors / T. Perekhrestenko, M. Diachenko, I. Sviezhentseva et al. // Georgian Med News, 2015. – Vol. 240. – P. 43–50.
Bixby D. Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance / D. Bixby, M. Talpaz // Hematology. American Society of Hematology. Education Program, 2009. – P. 461–476.
In Silico Design of Protein Kinase Inhibitors: Successes and Failures / G. G. Dubinina, O. O. Chupryna, M. O. Platonov et al. // Anticancer Agents Med Chem., 2007. – Vol. 7(2). – P. 171–88.
Dubinina G. G. Compound of 1,4-disubstituted 5-amino-1,2dihydropyrrole-3-one having anticancer activity / G. G. Dubinina, Yu. M. Volovenko. – Pat. 22204 (UA). 21.02.2006. Appl. U200601855. 25.04.2007.
Antiproliferative activity of the new derivatives of 1-(4-R-benzyl)-3R1-4-(R2-phenylamino)-1Н-pyrrole-2,5-dione / G.G. Dubinina, S. M. Golovach, V. O. Kozlovsky et al. // J. Organ ta Farm Khimii (Ukraine), 2007. – Vol. 5, N 1. – P. 39–49.
Garmanchuk L. V. MI-1 – derivative of maleimide inhibits cell cycle progression in tuomor cells of epithelial origin / L. V. Garmanchuk, E.O. Denis, V.V. Nikulina et al. // Biopolymers and Cell, 2013. – Vol. 29, N 1. – P. 70–74.
Lynchak O.V. The influence of the maleimide derivative on the condidtion of the normal rat liver and bowel and with chemical-induced carcinogenesis of the colon. Synopsis Dissertat. For Scientif. Degree of Candidate the Biol Scienc. Кyiv, 2010:1–20.
Potential cytostatic effect of the Maleimide derivative 1-(4-Сlbenzyl)-3-Cl-4-(CF3-phenylamino)-1Н-pyrrole-2,5-dione / L.V. Garmanchuk, O.V. Linchak, V.V. Niculina et al. // Eksperimental'naya i Klinicheskaya Farmakologiya. –2013. – Vol. 76, N 8. – P. 39–42.
Byelinska I. V. Hematological effects of the protein kinases inhibitor maleimide derivative of dimethylhydrazine-induced colorectal carcinogenesis of rats / I.V. Byelinska, O. V. Lynchak, T. V. Rybalchenko et al. // Fiziolohichnyǐ zhurnal (Ukrain), 2014. – Vol. 60, N 4. – P. 40–49.
Effect of maleimide derivative on oxidative stress and glutathione antioxidant system in 1,2–dimethylhydrazine induced colon carcinogenesis in rat / O. Filinska, S. Yablonska, S. Mandryk et al. // Annales Universitatis Mariae Curie-Sklodowska. Sectio DDD: Pharmacia, 2010. – Vol. 23, N 2. – P. 189–192.
State of the liver antioxidant system and content of matrix metalloproteinase-2 of large intestine under the effect of maleimide derivative in experimental colon carcinogenesis in rats / O. M. Filinska, S. V. Yablonska, S. Y. Mandryk et al. // Ukrain'skyi biokhimicheskiy zhurnal, 2010. – Vol. 82, N 4. – P. 69–77.
Morphofunctional state of blood cells after chronic exposure of the protein kinase inhibitor maleimide derivative / I.V. Byelinska, O.V. Lynchak, S.M. Tsyvinska et al. // Fiziolohichnyǐ zhurnal (Ukraine), 2015. – Vol. 61, N 4. – P. 71–77.
Effect of maleimide derivative on the morpho-functional state of the kidney in experimental colon carcinogenesis in rats / I. V. Kharchuk, O.M. Filins'ka, S.V. Yablons'ka et al. // Fiziolohichnyǐ zhurnal (Ukraine), 2010. – Vol. 56, N 6. – P. 62–69.
The structure functional status of rat kidney and pancreas after the long-term influence of novel targeted-action compound – maleimide derivative / I. V. Kharchuk, O. M. Filinska, S. V. Yablonska et al. // Reports of the National Academy of Sciences of Ukraine, 2010. – N 7. – P. 150–154.
Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway / D. Kent, M. Copley, C. Benz et al. // Clinical Cancer Research, 2008. – Vol. 14, N 7. – P. 1926–1930.
JAKs, STATs and Src kinases in hematopoiesis / S.G. Rane, E.P. Reddy et al. // Oncogene, 2002. – N 21. – P. 3334–3358.
Theroleof PKC and PDK1 in monocyte lineage specification by Ras / L. Pearn, J. Fisher, A.K. Burnett, R.L. Darley // Blood., 2007. – Vol. 109, N 10. – P. 4461–4469.
Comparative Analysis of the Antineoplastic Activity of C60 Fullerene with 5-Fluorouracil and Pyrrole Derivative In Vivo / O.V. Lynchak, Yu.I. Prylutskyy, V.K. Rybalchenko et al. // Nanoscale Research Lett., 2017. – Vol. 12, N 1. – P. 1-8.
Alekseev V.V. Medical laboratory technology. Manual of Clinical Laboratory Diagnostics / V.V. Alekseev, A.I. Karpishchenko – Moscow : GEOTAR-Media, 2012.
Byelinska I.V. Megakaryocytes morphology in indiopathic (primary) myelofibrosis / I.V. Byelinska, I.N. Kabachenko, I.S. Dyagil // Reports of Practical Oncology and Radiotherapy, 2004. – Vol. 9, N 6. – P. 223–228.
Grzhibovskiy A. M. Analysis of three or more independent groups of quantitative data / A.M. Grzhibovskiy // Ecology of human (rus.), 2008. – N 3. – P. 50–58.
Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release / G. Mattia, F. Vulcano, L. Milazzo et al. // Blood., 2002. – Vol. 99. – P. 888–897.
Deutsch V.R. Megakaryocyte development and platelet production / V.R. Deutsch, A. Tomer // British Journal of Haematology, 2006. – Vol. 134, N 5. – P. 453–466.
Understanding platelet generation from megakaryocytes: implications for in vitro–derived platelets / X. Sim, M. Poncz, P. Gadue et al. // Blood., 2016. – Vol.127, N 10. – P. 1227–1233.
Abnormal megakaryocyte development and platelet function in Nbeal22/2 mice / H.A. Kahr Walter, R.W. Lo, L. Li et al. // Blood., 2013. – Vol. 122, N 19. – P. 3349–3358.
Developmental changes in human megakaryopoiesis / O. Bluteau, T. Langlois, P. Rivera-Munoz et al. // Journal of Thrombosis and Haemostasis, 2013. – Vol. 11, N 9. – P. 1730–1741.
Pitchford S.C. VEGFR1 timulates a CXCR4–dependent translocation of megakaryocytes to the vascular niche, enhancing platelets production in mice / S.C. Pitchford, T. Lodie, S.M. Rankin // Blood., 2012. – Vol. 120, N 14. – P. 2787–2795.
VEGFR–3 is expressed on megakaryocyte precursors in the murine bone marrow and plays a regulatory role in megakaryopoiesis / W. Thiele, J. Krishnan, M. Rothley et al. // Blood., 2012. – Vol. 120, N 9. – P. 1899–1907.
Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCζ or mTOR in TPO-dependent cell lines and primary megakaryocytes / S Chanprasert, A.E. Geddis, C. Barroga et al. // Cellular Signalling, 2006. – Vol. 18, N 8. – P. 1212–1218.
PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27Kip1 / T. Nakao, A.E. Geddis, N.E. Fox et al. // Cell Cycle, 2008. – Vol. 7, N 2. – P. 257–266.
PDK1 regulates platelet activation and arterial thrombosis / X. Chen, Y. Zhang, Y. Wang et al. // Blood., 2013. – Vol. 121, N 18. – P. 3718–3726.
Yena M.S. Comparative Influence of Cytostatics Maleimide Derivative and 5-Fluoruracil on Rat Caecum Mucosa / M.S. Yena, H.M. Kuznietsova, V.K. Rybalchenko // Bulletin of Problems Biology and Medicine, 2014. – Vol. 4, N 3. – P. 133–137.
Effect of different doses of protein kinase inhibitor maleimide derivative on state of rat caecum mucosa] / M.S. Yena, H.M. Kuznietsova, O.V. Lynchak et al. // Problems of Ecologycal and Medical Genetics and Klinical Immunology, 2013. – Vol. 6, N 120. – P. 21–27.
Effect of dihydropyrrol and maleimide derivatives on the state of the liver and colon in normal rats and those with colorectal carcinogenesis induced by dimethylhydrazine / H.M. Kuznietsova, O.V. Lynchak, M.O. Danylov et al. // Ukrainskiǐ biokhimicheskiǐ zhurnal, 2013. – Vol. 85, N3. – P. 62-67.
DOI: http://dx.doi.org/10.17721/2616_6410.2017.22.16-20
Refbacks
- There are currently no refbacks.
This journal is available according to the Creative Commons License «Attribution» («Атрибуція») 4.0 Global (CC-BY).